Blog

 

Categories:

  • March 31, 2025
  • Post by Julie Bick, Ph.D.

Mental Health: I had a patient who was on Lexapro, a very common antidepressant. But this was not her first antidepressant. She was previously on Celexa but had switched to Lexapro because Celexa was ineffective. She reported she did not feel like the Lexapro was working very well for her either.

Read moredown-icon
  • March 31, 2025
  • Post by Julie Bick, Ph.D.

Who Is Affected? Doctors and health care providers play a crucial role in ensuring patients receive the right medications. Patients who experience severe side effects or ineffective treatments due to genetic differences can benefit from personalized prescriptions guided by pharmacogenomics (PGx). The right drug, the right dose for the right patient.

Read moredown-icon
  • March 31, 2025
  • Post by Julie Bick, Ph.D.

Who Is Affected? Employers and their workforces can benefit from understanding how medications impact productivity and well-being. Employees who experience severe side effects or ineffective treatments may have higher absenteeism, reduced efficiency, and increased health care costs.

Read moredown-icon
  • March 31, 2025
  • Post by Julie Bick, Ph.D.

Who Is Affected? Anyone who takes medication can benefit from understanding how their body processes drugs. Some people experience severe side effects, while others don’t get the full benefit of their prescriptions due to genetic differences.

Read moredown-icon
  • March 31, 2025
  • Post by Julie Bick, Ph.D.

Medication Safety Week serves as a crucial reminder of the importance of ensuring that medications are used safely and effectively. While traditional medication practices rely on general guidelines, the field of pharmacogenomics (PGx) is changing the way drugs are prescribed and administered and moving us towards a precision medicine approach to healthcare.

Read moredown-icon
  • March 12, 2025
  • Post by Julie Bick, Ph.D.

March is Kidney Disease Awareness Month, a month dedicated to increasing awareness about kidney health and improving treatment strategies for those affected by chronic kidney disease (CKD). One of the most promising advancements in nephrology today is pharmacogenomics (PGx)- the study of how a person’s genetic makeup affects their response to medications. As kidney disease continues to impact millions worldwide, personalized medicine through PGx offers a real opportunity to optimize treatments and improve patient outcomes.

Read moredown-icon
  • March 5, 2025
  • Post by Julie Bick, Ph.D.

Healthcare costs continue to rise year after year, and employers are seeking innovative ways to manage these expenses while maintaining or improving employee health benefits. One emerging strategy is the use of PGx testing to optimize medication use and improve health outcomes.

Read moredown-icon
  • February 17, 2025
  • Post by Dean Ihemesie

Precision medicine, a relatively newer approach to healthcare, can tailor treatment and prevention strategies to an individual’s unique genetic profile, environment, and lifestyle. Instead of a universal approach, precision medicine acknowledges our individual biological differences, understanding that effective treatment for one person may not be optimal for another, it recognizes our biological diversity and the fact that treatment may vary from person to person.

Read moredown-icon
  • February 6, 2025
  • Post by Julie Bick, Ph.D.

With the development of precision medicine protocols, genetic profiling is becoming standard-of-care in many areas of medicine. The combination of genetics and pharmacology has led to the development of pharmacogenomics—a field that explores how an individual’s genetic makeup influences their response to medications.

Read moredown-icon
  • January 23, 2025
  • Post by Julie Bick, Ph.D.

Pharmacogenomics or PGx, is the study of how an individual’s genetic makeup influences their response to medications. Due to its relatively low cost and high clinical potential PGx has been at the forefront of personalized medicine for several years. As global healthcare incorporates new technologies, countries worldwide are now adopting PGx testing to optimize drug therapies, reduce adverse drug reactions, and improve patient outcomes. This blog explores how various nations have integrated PGx into their healthcare systems, highlighting achievements, challenges, and unique approaches.

Read moredown-icon
  • January 7, 2025
  • Post by Julie Bick, Ph.D.

PGx represents a transformative approach in cancer treatment that utilizes the genetic makeup of both the patient and their cancer to personalize and optimize their cancer therapy, while minimizing adverse effects. It is a crucial component of precision medicine, offering a more targeted process compared to traditional cancer treatments. In this blog, we’ll explore the history, principles, and applications of PGx in oncology, as well as its challenges and future prospects.

Read moredown-icon
  • December 3, 2024
  • Post by Julie Bick, Ph.D.

Pharmacogenomics (PGx) is the study of how genes affect a person’s response to drugs, and it represents a relatively easy and low-cost entry point into personalized medicine. The goal of PGx is to tailor medical treatments to individuals based on their genetic makeup, improving drug efficacy and minimizing the risks of adverse effects. Despite its growing role in healthcare, some skepticism lingers. In this blog, we’ll explore why some people remain unconvinced of its value to patients, and ultimately how barriers to the adoption of PGx will be overcome within the healthcare sector.

Read moredown-icon
  • November 21, 2024
  • Post by Julie Bick, Ph.D.

PGx represents a transformative approach in cancer treatment that utilizes the genetic makeup of both the patient and their cancer to personalize and optimize their cancer therapy, while minimizing adverse effects. It is a crucial component of precision medicine, offering a more targeted process compared to traditional cancer treatments. In this blog, we’ll explore the history, principles, and applications of PGx in oncology, as well as its challenges and future prospects.

Read moredown-icon
  • November 8, 2024
  • Post by Julie Bick, Ph.D.

Pharmacogenomic (PGx) testing assesses how an individual’s genetic makeup affects their response to medications, and as such, is proving to be an important step towards personalized medicine [1]. By tailoring drug therapy to the patient’s genetic profile, PGx testing can enhance treatment efficacy, reduce adverse drug reactions, and improve overall patient outcomes. Despite its potential, the widespread adoption and insurance coverage of PGx testing currently remains limited. Many in the healthcare sector have expressed concerns about the lack of robust, high-quality evidence to demonstrate the clinical utility of PGx testing, and while numerous studies highlight the potential benefits, insurers and healthcare providers continue to request clear evidence for its cost-effectiveness as well as benefits to patients [2].

Read moredown-icon
  • October 10, 2024
  • Post by Julie Bick, Ph.D.

In recent years, the field of PGx has rapidly gained attention in the healthcare industry for its ability to enhance patient care by customizing medication protocols based individual genetic profiles. The potential of PGx testing is substantial, enabling healthcare providers to transform their approach to drug prescriptions, reduce side-effects and adverse drug reactions (ADRs), improve therapeutic efficacy, and to ultimately improve and save lives of patients. In this blog, we outline what PGx testing is, how it works, its benefits, challenges, and how it is actively contributing to patient safety today within our healthcare systems.

Read moredown-icon
Contact Us Button